Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers

NCT02326337 is registered in ClinicalTrials.gov with AOTI Ltd. as lead sponsor.

NCT NCT02326337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Lead sponsor
AOTI Ltd.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
October 25, 2018
Enrollment
73 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer